NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » TOP China Pharmas » China Aoxing Pharmaceutical Company, Inc.  1    
found files: 16
China Aoxing Pharmaceutical Company, Inc. »26/11/2007 [Company watch]
China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA

China Aoxing Pharmaceutical Company, Inc. , which has the largest manufacturing facility and product pipeline for highly regulated narcotic medicines and pain medication in China, today announced that the China State Food & Drug Administration (SFDA) granted the Company the designated manufacturer status to produce Tilidine Tablets and Capsules, a highly regulated narcotic drug, in order to address significant unmet medical needs in cancer pain management in China. Maybe a working partner?...   more»


China Aoxing Pharmaceutical Company, Inc. »13/03/2008 [Company watch]
China Aoxing Pharmaceutical to Acquire Shijiangzhuang Lerentang Pharmaceutical Co.,

China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd. -Acquisition to Expand Company's Market Position and Portfolio in Pain Management- China Aoxing Pharmaceutical Company, Inc. which has the largest manufacturing facility and product pipeline for highly regulated narcotic medicines and pain medication in China, today announced that Hebei Aoxing Pharmaceutical Group Company, the subsidiary of China Aoxing Pharmaceutical Company, signed a definitive acquisition agreement to acquire Shijiazhuang Lerentang Pharmaceutical Company Ltd. ("LRT"). LRT is a pharmaceutical company organized under the laws of China specializing in the manufacturing and distribution of modernized Chinese traditional medicines, with a strong portfolio of pain management products. . developed a rich line of pain management drugs in pills, tablets, capsules, oral solutions and other formulations. LRT's best selling product is the Zhong Tong An Capsules, an effective pain medicine developed solely by LRT to relieve dental pain, sore throats and oral ulcers. Zhong Tong An Capsules accounted for approximately 50% of LRT's total revenue in 2007. LRT currently has 52 products listed in the first and second classes of the National Medical Insurance Program, and 101 products entered in the national OTC medicine book. In 2004, LRT passed GMP production certificates for all of its production lines. "We are excited to gain significant progress in the LRT transaction and believe this acquisition will further support our position as a leading, diversified pain management products company," commented Zhenjiang Yue, Chairman and CEO of China Aoxing. "With LRT's integration, we will execute a key part of our business strategy by acquiring an established brand, profitable business, and synergistic product portfolio with significant commercialization value. LRT has a number of high value pain management products,...   more»


China Aoxing Pharmaceutical Company, Inc. »18/04/2008 [Company watch]
American Oriental Bioengineering Inc. in JV with China Aoxing Pharmaceutical Company

American Oriental Bioengineering Inc. (NYSE: AOB) took a 38% position in China Aoxing Pharmaceutical Company Inc. (OTCBB: CAXG.OB) as part of a deal under which the two companies will jointly develop and market narcotics and pain relievers in China. American Oriental will pay $18 million for 30 million shares of China Aoxing, a price of 60 cents per share. China Aoxing last traded at $1.22 per share, and it moved up 22 cents to $1.54 following the announcement. China Aoxing concentrates on highly regulated narcotic pain drugs. Only a few China biopharmas have permission to develop narcotic drugs. In March, China Aoxing agreed to acquire Shijiazhuang Lerentang Pharmaceutical Company, another company with pain drugs in its portfolio, for 8 million shares of stock and $10.8 million in cash, even though China Aoxing listed only $1 million in cash available. The investment by American Oriental allowed China Aoxing to close its purchase of Shijiazhuang Lerentang. American Oriental had $166 million in cash at the end of 2007, and it has been very intent upon increasing its business by buying companies, though usually it has acquired 100% of privately held biopharmas. In 2007, it made at least four such transactions. The company reported its 2007 profits were $43.3 million on revenues of $160.5 million. The companies noted that the narcotic and pain market in China is currently worth only $300 million annually, implying patients are vastly underserved. China Aoxing and American Oriental Bioengineering will collaborate on increasing the sales of China Aoxing's current pain drugs, particularly Naloxone, and they will also work to further development of China Aoxing's narcotic drug pipeline, which includes Oxycodone and Tilidine....   more»


China Aoxing Pharmaceutical Company, Inc. »18/11/2008 [Company watch]
China Aoxing Pharmaceutical Company Announces First Quarter Fiscal Year 2009 Financial Results

Revenues increased 161% year over year...   more»


China Aoxing Pharmaceutical Company, Inc. »12/12/2008 [Company watch]
China Aoxing Pharmaceutical Company obtains production licence

China Aoxing Pharmaceutical Company, a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, Ltd., received a new production license from the China State Food and Drug Administration for Paracetamol and Caffeine Tablets, a controlled substance regulated by the SFDA....   more»


China Aoxing Pharmaceutical Company, Inc. »17/12/2008 [Company watch]
China Aoxing Pharmaceutical Company Receives a New Injectable Drug Approval for Treating Ischemic Cerebrovascular Disease

China Aoxing Pharmaceutical Company, today announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, Ltd., received a new production license for Ligustrazine Phosphate Injection from the China State Food and Drug Administration (\"SFDA\") for treatment of ischemic cerebrovascular disease, or ischemic stroke....   more»


China Aoxing Pharmaceutical Company, Inc. »20/04/2009 [Company watch]
China Aoxing Pharmaceutical Company, Inc. Receives GMP Certification for Tablet Dosage Form of Pharmaceutical Products

China Aoxing Pharmaceutical Company, Inc. a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it has received the Good Manufacturing Practice (GMP) certification for its recently opened tablet formulation and packaging production facility....   more»


China Aoxing Pharmaceutical Company, Inc. »21/04/2009 [Company watch]
China Aoxing gets GMP certification for new facility

The company has received the Good Manufacturing Practice (GMP) certification for its recently opened tablet formulation and packaging production facility....   more»


China Aoxing Pharmaceutical Company, Inc. »23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products

China Aoxing Pharmaceutical Company, Inc., a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it has received renewal of the Good Manufacturing Practice (GMP) certification for its capsule formulation and packaging production facility....   more»


China Aoxing Pharmaceutical Company, Inc. »07/08/2009
China Aoxing Pharmaceutical Corp. (CAXG) Announces Completion of $5 Million Private Placement of Common Stock

China Aoxing Pharmaceutical Company, Inc.a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has completed a private placement with a total of fifteen institutional and other accredited investors of 5,263,158 shares of the Companys common stock at a purchase price of $0.95 per share, for gross proceeds of $5 million....   more»


China Aoxing Pharmaceutical Company, Inc. »12/08/2009 [Company watch]
China Aoxing Alleviates Liquidity Needs with Sale of 5.2 Million Shares

China Aoxing Pharmaceutical Company raised $5 million by selling 5.2 million shares at a price of $.95 each. The sale was made without an agent to fifteen institutional and other accredited investors....   more»


China Aoxing Pharmaceutical Company, Inc. »17/09/2009 [Company watch]
China Aoxing Receives SFDA Approval for Clinical Trial of Abuse Resistant Opioid Drug

China Aoxing, today announced that its Clinical Trial Application for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration. CTA approval is a key SFDA requirement prior to pursuing a clinical trial...   more»


China Aoxing Pharmaceutical Company, Inc. »24/09/2009 [Company watch]
China Aoxing Awarded Centre of Excellence in Enterprise Technology

China Aoxing Pharmaceutical Company, Inc. a China-based pharmaceutical company specialising in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that China Aoxing honourably received Centre of Excellence Award in Enterprise Technology by the consortium of China local government offices....   more»


China Aoxing Pharmaceutical Company, Inc. »20/01/2010 [Industry news]
China Aoxing Pharmaceutical Corp. Announces Appointment of New Chief Financial Officer

China Aoxing Pharmaceutical Company, Inc., a pharmaceutical company specialising in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it has appointed Dr. Hui Shao as Chief Financial Officer, effective immediately....   more»


China Aoxing Pharmaceutical Company, Inc. »14/04/2010 [Company watch]
China Aoxing Pharmaceutical Corp. Approved to List on NYSE AMEX

Aoxing Pharmaceutical Company, Inc, a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it received authorisation to list its common stock on the NYSE AMEX market....   more»


China Aoxing Pharmaceutical Company, Inc. »26/04/2010
Aoxing andJohnson Matthey Announce China JV for Narcotic APIs

Aoxing Pharmaceutical Company Inc. today announced that Aoxing Pharma and Johnson Matthey Plc have entered into an agreement to establish a joint venture through affiliated companies focused on research, development, manufacturing and marketing of active pharmaceutical ingredients (\"API\') for narcotics and neurological drugs for the China market....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.